“CURRENT PHARMACEUTICAL REGULATIONS OF UNITED KINGDOM: POST BREXIT” (2022) Journal of Pharmaceutical Negative Results, pp. 3406–3415. doi:10.47750/pnr.2022.13.S06.455.